Aker BioMarine ASA (FRA:1PG) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1PG Aker BioMarine ASA FRA:1PG
58 GF Score
Price €11.86
GF Value €6.79
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aker BioMarine ASA Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Aker BioMarine ASA is: High Risk: High uncertainty with risk-return tradeoff.

Aker BioMarine ASA  (FRA:1PG) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Aker BioMarine ASA Risk Assessment Related Terms

FRA:1PG vs KHC, GIS, MKC: Risk Assessment Comparison

For the Packaged Foods subindustry, Aker BioMarine ASA's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aker BioMarine ASA Risk Assessment vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Risk Assessment falls into.


FRA:1PG
58GF Score
Aker BioMarine ASA FRA:1PG
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aker BioMarine ASA (FRA:1PG) Overvalued in 2026?

Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued. The current stock price of €11.86 is trading 74.7% above its estimated GF Value™ of €6.79. GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.

Key valuation signals for FRA:1PG:

  • Risk Assessment:
  • GF Value™: €6.79 vs. price of €11.86 (74.7% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the FRA:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aker BioMarine ASA Business Description

Address Oksenoyveien 10, Lysaker, NOR, 1366
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
58GF Score

Get the complete analysis for FRA:1PG

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.86
Price
€6.79
GF Value